Cardinal Health to Acquire Harvard Drug Group for $1.115 Billion
June 05, 2015 at 22:00 PM EDT
On Friday, June 5, Cardinal Health, Inc. (NYSE:CAH) announced that it would acquire The Harvard Drug Group for $1.115 billion. (Source: Cardinal Health, June 5, 2015.) Cardinal Health is a healthcare services company specializing . . . → Read More: Cardinal Health to Acquire Harvard Drug Group for $1.115 Billion Similar Articles: Stock Update (NYSE:ACT): Eli Lilly loses Alimta drug patent case in Germany to Actavis Stock Update: General Motors Company (NYSE:GM) – Exclusive: GM turns to banks to help deal with activist investor group Market Update (NYSE:TGT): Gravie partners with Target on in-store health insurance advice
